Cargando…

Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy

BACKGROUND: Previous trials have shown improved efficacy of neoadjuvant treatment when combined with angiotensin II receptor antagonist, losartan in patients with locally advanced pancreatic ductal adenocarcinoma (PDA). However, role of losartan is unknown in metastatic PDA. In this retrospective ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasi, Anup, Allen, Jessica, Mehta, Kathan, Dandawate, Prasad, Saha, Subhrajit, Bossmann, Stefan, Anant, Shrikant, Sun, Weijing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Whioce Publishing Pte. Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177858/ https://www.ncbi.nlm.nih.gov/pubmed/34104829

Ejemplares similares

Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer
por: Bhattacharyya, Sangita, et al.
Publicado: (2023)

Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
por: Park, Robin, et al.
Publicado: (2020)

Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies
por: Standing, David, et al.
Publicado: (2023)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
por: Allen, Jessica, et al.
Publicado: (2020)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
por: Ramamoorthy, Prabhu, et al.
Publicado: (2021)

Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma
por: McGinnis, Timothy, et al.
Publicado: (2020)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
por: Hentzen, Stijn, et al.
Publicado: (2023)

Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
por: Angulo, Pablo, et al.
Publicado: (2017)

Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer
por: Escher, Taylor E., et al.
Publicado: (2021)

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review
por: Kasi, Anup, et al.
Publicado: (2020)

Immunoglobin A Deficiency and Squamous Cell Carcinoma With a Rare Presentation as Anal Cancer
por: Kasi, Anup, et al.
Publicado: (2022)

Pancreatitis aguda en un paciente tratado con losartán
por: Arellano, Lucía, et al.
Publicado: (2014)

Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis
por: Subramaniam, Dharmalingam, et al.
Publicado: (2021)

Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Suppressing STAT5 signaling affects osteosarcoma growth and stemness
por: Subramaniam, Dharmalingam, et al.
Publicado: (2020)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
por: Li, Qing, et al.
Publicado: (2022)

Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chidharla, Anusha, et al.
Publicado: (2023)

Is obesity a risk factor in cancer patients with COVID-19?
por: Park, Robin, et al.
Publicado: (2021)

Sequential therapy for pancreatic cancer by losartan- and gemcitabine-loaded magnetic mesoporous spheres
por: Li, Yanjun, et al.
Publicado: (2019)

Delayed-Onset Losartan-Induced Pancreatitis Secondary to an Overdose: A Case Report
por: Khatri, Shivam, et al.
Publicado: (2023)

Personalization of Chemotherapy for Metastatic Pancreatic Cancer
por: Sasahara, Yuriko (Ito), et al.
Publicado: (2014)

Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells
por: Ponnurangam, Sivapriya, et al.
Publicado: (2015)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway
por: Dandawate, Prasad, et al.
Publicado: (2020)

Paraneoplastic Necrotizing Myopathy Post Lumpectomy and Chemotherapy for Early Breast Cancer
por: Venkatesh, Priyanka, et al.
Publicado: (2020)

Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma
por: Ghosh, Hindole, et al.
Publicado: (2023)

Noninvasive Assessment of Losartan-Induced Increase in Functional Microvasculature and Drug Delivery in Pancreatic Ductal Adenocarcinoma()
por: Kumar, Vidhya, et al.
Publicado: (2016)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone
por: Krishnamachary, Balaji, et al.
Publicado: (2019)

Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan
por: Ito, Sadayoshi, et al.
Publicado: (2012)

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
por: Bengtson, Charles D., et al.
Publicado: (2021)

Changes in Pharmacokinetics and Pharmacodynamics of Losartan in Experimental Diseased Rats Treated with Curcuma longa and Lepidium sativum
por: Ahad, Abdul, et al.
Publicado: (2022)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rf93rrm722uqmbh4cnt5t7364f